Driven in part by retroactive fees imposed upon pharmacies by pharmacy benefit managers (PBMs) and compounded by recent high profile cases of significant price increases for relatively common drugs, both retail and institutional pharmacies have continued to push for enhanced prescription drug pricing transparency. Recent state and federal legislation, as well as lawsuits…